Pump fun's has only one real competitor: Axiom.Weirdly, CT is quiet about it.I missed $HYPE airdrop, but I'm not missing $AXIOM-----Axiom consistently trails Pump on daily fees, often generating more than Solana itself.Backed by YCombinator "Axiom the fastest company in YC history to hit $100m in real top-line revenue"It "took Cursor 12 months to hit same $100m" - @TheOneandOmsyInterestingly, Axiom official X account and co-founders are keeping a very low profile on X with very few posts.Marketing is spread ...

First-in-human trial of AX-0810 will evaluate safety, tolerability, pharmacokinetics, and target engagement in healthy volunteers with initial data expected in Q4 2025Marks the first submitted Clinical Trial Application (CTA) advancing ProQR’s Axiomer™ ADAR-mediated RNA editing platform into clinical development LEIDEN, Netherlands & CAMBRIDGE, Mass., June 26, 2025 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies bas ...

are you thinking about using Axiom well before you do you need to watch this video that's because we're about to walk you through everything you need to know to get started on Axiom step by step so you can get the most out of this powerful DeFi trading terminal we'll also share some essential tips and tricks to help you trade safely and efficiently valuable insights you won't find anywhere else so make sure you stick around until the very end my name is Guy let's get started okay before we get going it's im ...

New AXIOM model captures mainstream headlines and industry acclaimVANCOUVER, British Columbia, June 12, 2025 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE: VERS; OTCQB: VRSSF) (“VERSES” or the “Company”) a cognitive computing company specializing in next-generation agentic software systems today announced important third-party recognition of its digital-brain architecture, AXIOM, following features in WIRED and Popular Mechanics and public acknowledgement from ARC-AGI benchmark creator François Chollet. WIRED: A ...

Core Viewpoint - NASA and its partners have postponed the Axiom Mission 4 launch schedule and are reassessing the launch date [1] Group 1 - The postponement indicates potential delays in upcoming space missions, which may impact the overall timeline for commercial spaceflight initiatives [1] - The decision to reassess the launch date suggests that NASA is prioritizing safety and thorough evaluation of mission parameters [1]

VERSES new AXIOM model is up to 60% better, 97% more efficient and learns 39 times faster than Google® Deepmind’s DreamerV3 in third-party validated benchmarkVANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE: VERS) (OTCQB: VRSSF) (“VERSES” or the “Company”), a cognitive computing company, today revealed results that it believes mark a significant advancement in artificial intelligence. Their new digital brain architecture, codenamed AXIOM (Active eXpanding Inference with Ob ...

Axiomer™ ADAR-mediated RNA editing pipeline advancing across liver and CNS programs, with CTA filing on track for Q2 2025 for lead program AX-0810 targeting NTCP for Cholestatic diseases Strengthened leadership with appointments of Chief Financial Officer and Chief Medical Officer€ 132.4 million cash and cash equivalents as of end Q1 providing runway into mid-2027, plus additional potential milestones from Lilly partnership LEIDEN, Netherlands & CAMBRIDGE, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- ProQR Thera ...

Company Overview - ProQR Therapeutics NV is focused on developing transformative RNA therapies using its proprietary Axiomer RNA editing technology platform [1][4] - The company aims to create a new class of medicines targeting both rare and prevalent diseases with unmet medical needs [4] Axiomer Technology - Axiomer is a next-generation RNA base editing technology that allows for specific single nucleotide changes in RNA [3][4] - The technology utilizes the human cell's own ADAR (Adenosine Deaminase Acting on RNA) machinery to convert Adenosine (A) to Inosine (I), which is then translated as Guanosine (G), effectively correcting disease-causing mutations [3] Upcoming Events - ProQR management is scheduled to present at the Citizens (JMP) Life Sciences Conference in New York City on May 8, 2025, at 11:30 AM EDT [1] - A live webcast of the presentation will be available on ProQR's website, with a replay accessible for approximately 30 days [2]

LEIDEN, Netherlands & CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today announced the Annual General Meeting (AGM) of Shareholders will take place on Tuesday, June 3, 2025 at 1530 CEST at the offices of Allen Overy Shearman Sterling LLP, in Amsterdam, the Netherlands. All relevant documents and information for the ...